Actelion announces definitive agreement to acquire US-based CoTherix, Inc. (21 Nov 2006)
Actelion Ltd announced that it has entered into a definitive agreement to acquire CoTherix, Inc., a biopharmaceutical company with its headquarters in Brisbane, California. CoTherix currently markets Ventavis® (iloprost), the only...
VaxGen Forms Joint Venture to Build Manufacturing Facilities in California and South Korea (27 Feb 2002) Facilities Designed to Support Potential Regulatory Approval and Commercial Manufacture of VaxGen's AIDS Vaccine BRISBANE, Calif. and SEOUL – February 25, 2002 – VaxGen, Inc. and a group of South Korean investors today announced the formation of a joint venture, which will invest approximately $120 million to build and operate a facility in Incheon...
Top
